Our full disclaimer, terms of use, and privacy policy. Please read these carefully before using any ApexLens Capital content or services.
ApexLens Capital LLC is not a registered investment adviser, broker-dealer, or financial planning firm. Nothing on this website, in our newsletters, or in any of our publications constitutes investment advice, a solicitation to buy or sell any security, or a personalized financial recommendation.
All content published by ApexLens Capital — including stock picks, ETF picks, price targets, model portfolios, market commentary, educational articles, and any other material — is provided strictly for informational and educational purposes only.
The information presented reflects the personal research opinions of our analysts at a specific point in time and may not be updated. Market conditions change rapidly, and opinions expressed may no longer be current or accurate by the time you read them.
References to past performance of any investment, security, or trading strategy do not guarantee or imply similar future results. All investing involves risk, including the possible loss of some or all of the principal amount invested. Some strategies may carry additional risks, including but not limited to liquidity risk, concentration risk, and the risk of total loss.
ApexLens Capital does not know your individual financial situation, risk tolerance, investment objectives, time horizon, tax circumstances, or personal goals. Our research is written for a general audience. Before making any investment decision, you should consult with a qualified, licensed financial professional who can assess your specific circumstances.
We may reference data, estimates, or information from third-party sources including company filings, earnings transcripts, market data providers, and news organizations. While we strive for accuracy, ApexLens Capital makes no representations or warranties regarding the completeness, accuracy, or timeliness of third-party data.
By accessing or using the ApexLens Capital website (apexlenscapital.com) or any of our publications, you agree to the following terms. If you do not agree, please do not use our services.
You must be at least 18 years of age to use this website. By accessing it, you represent and warrant that you meet this requirement and that your use complies with all applicable laws and regulations in your jurisdiction.
Our content is licensed for personal, non-commercial use only. You may:
You may not, without our express written permission:
Subscription accounts are for individual use only and may not be shared. ApexLens Capital reserves the right to suspend or terminate accounts that violate these terms. Subscription fees are billed in advance and are generally non-refundable, except where required by applicable law.
This website and all content are provided "as is" and "as available" without warranty of any kind, express or implied. ApexLens Capital does not warrant that the website will be uninterrupted, error-free, or free of viruses or other harmful components.
To the maximum extent permitted by law, ApexLens Capital LLC, its officers, directors, employees, and analysts shall not be liable for any direct, indirect, incidental, consequential, or punitive damages arising out of your use of our content or services, including any investment losses incurred in reliance on our research.
These terms are governed by the laws of the State of New York, United States, without regard to conflict of law principles. Any disputes shall be resolved in the state or federal courts located in New York County, New York.
ApexLens Capital is committed to independent, conflict-free research. Our editorial standards are designed to protect the integrity of our analysis and the interests of our readers.
ApexLens Capital does not accept advertising, sponsored content, affiliate fees, or payments from any company we cover or might cover. We do not accept compensation from broker-dealers for directing order flow or promoting specific securities. Our revenue comes exclusively from reader subscriptions.
If we publish factual errors, we correct them promptly and transparently. Corrections are noted within the original article with a date stamp. We do not silently edit published research to change substantive conclusions without disclosure.
Our analysts conduct original fundamental research using publicly available information: SEC filings (10-K, 10-Q, 8-K), earnings call transcripts, company presentations, industry reports, and publicly available market data. Price targets are based on a blended valuation model including DCF analysis, comparable multiples, and historical trading range. All assumptions and key inputs are disclosed in the body of each research note.
ApexLens Capital requires all research analysts to disclose personal financial interests in securities they cover. The following disclosure policy applies to all published research:
| Requirement | Policy |
|---|---|
| Personal positions | All analyst personal positions in covered securities must be disclosed at the bottom of every research note. Disclosures are updated within 5 business days of any change. |
| Trading blackout | Analysts may not buy or sell a covered security within 72 hours before or after publishing a new or updated research note on that security. |
| Conflicts of interest | Analysts must disclose and recuse themselves from coverage of any security in which they have a material personal relationship with the issuer. |
| Family accounts | Disclosures include positions held by analysts' immediate family members in the same household. |
These disclosures apply to individual research notes and are not reproduced in aggregate on this page. See the bottom of each research article for specific analyst disclosures applicable to that publication.
Certain statements in our research constitute "forward-looking statements" within the meaning of applicable securities laws. These include statements about future events, price targets, earnings estimates, business outlook, industry trends, and other matters that are not purely historical facts.
Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. Factors that could cause actual results to differ include:
We do not undertake any obligation to update or revise forward-looking statements to reflect new information, future events, or otherwise, except as required by law.
ApexLens Capital collects limited personal information necessary to provide our services. We do not sell your personal data. Ever.
| Data Type | How Collected | Purpose |
|---|---|---|
| Email address | Newsletter signup, account registration, contact forms | Sending research publications, account management, responding to inquiries |
| Name | Account registration, contact forms | Personalizing communications, account management |
| Payment information | Subscription checkout (processed by Stripe) | Billing for paid subscriptions. We do not store full card numbers. |
| Usage data | Server logs, analytics (IP address, browser, pages visited) | Site performance, security, understanding content engagement |
We use the information we collect to:
We do not sell, rent, or trade your personal information to third parties for marketing purposes. We may share limited data with:
We retain your email address and account information for as long as your account is active or as needed to provide services. You may request deletion of your personal data at any time by contacting privacy@apexlenscapital.com. We will fulfill deletion requests within 30 days, except where we are required to retain data by law.
If you are a California resident (CCPA) or located in the European Economic Area (GDPR), you have additional rights including:
To exercise these rights, contact privacy@apexlenscapital.com.
We implement reasonable technical and organizational measures to protect your personal information from unauthorized access, disclosure, or destruction. These include encrypted data transmission (TLS/HTTPS), access controls, and regular security reviews. However, no method of transmission over the internet is 100% secure, and we cannot guarantee absolute security.
Our website uses cookies and similar tracking technologies to improve your browsing experience and analyze site usage.
| Cookie Type | Purpose | Duration |
|---|---|---|
| Essential | Required for the website to function. Includes session management and security tokens. | Session / up to 1 year |
| Analytics | Help us understand how visitors use the site (page views, traffic sources). We use privacy-respecting, cookieless analytics where possible. | Up to 2 years |
| Preferences | Remember your settings such as display preferences or dismissed banners. | Up to 1 year |
You can control cookies through your browser settings. Disabling cookies may affect website functionality. We do not use third-party advertising cookies or tracking pixels for retargeted advertising.
All content on the ApexLens Capital website — including articles, research notes, pick lists, graphics, charts, logos, and design elements — is the intellectual property of ApexLens Capital LLC and is protected by United States and international copyright law.
Unauthorized reproduction, distribution, or creation of derivative works is strictly prohibited. Brief quotation with attribution is permitted under fair use principles.
If you believe that content on our site infringes your copyright, please send a written notice to our designated DMCA agent containing:
DMCA notices should be sent to: legal@apexlenscapital.com
For legal inquiries, copyright concerns, privacy rights requests, or compliance questions, please contact:
ApexLens Capital LLC — Legal Department
340 Madison Avenue, Suite 1200
New York, NY 10173
Email: legal@apexlenscapital.com
Privacy: privacy@apexlenscapital.com
We aim to respond to all legal inquiries within 5 business days.
These terms were last updated on April 1, 2025. ApexLens Capital reserves the right to modify these terms at any time. Material changes will be communicated to registered subscribers via email. Continued use of our services after changes take effect constitutes acceptance of the revised terms.
Independent research, straight to your inbox. Free weekly newsletter for self-directed investors.